• |

Richard T. Scott, Jr., M.D., HCLD

Dr. Richard T. Scott, Jr. NJDr. Scott, a board certified reproductive endocrinologist, obstetrician and gynecologist, is one of the founding partners of Reproductive Medicine Associates. He also serves as Professor and Division Director of Reproductive Endocrinology, Department of Obstetrics, Gynecology, and Reproductive Science, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey. Dr. Scott is also board certified by the American Board of Bioanalysis as an embryologist, andrologist, and high complexity clinical laboratory director. As director of laboratory services, he is responsible for the andrology, endocrinology, and embryology labs. This distinction makes him uniquely suited to integrate both clinical and laboratory services in a reproductive medicine practice. He completed his fellowship in reproductive endocrinology at the Jones Institute for Reproductive Medicine in Norfolk, Virginia, after receiving his medical degree from the University of Virginia Medical School. Dr. Scott is a recognized leader in the areas of ovulation induction for assisted reproduction, ovarian reserve screening, oocyte donation, embryology, and preimplantation genetic screening, and non-invasive screening of embryonic reproductive competence. Dr. Scott oversees three separate embryology labs in New Jersey, New York and Connecticut, and has completed more than 20,000 in vitro fertilization (IVF) cycles. He is an award-winning researcher and author of more than 200 scientific papers and abstracts, serves as an ad hoc reviewer for more than a dozen peer review journals, and has lectured to reproductive endocrinologists throughout the U.S. and abroad. He has received more than a dozen prestigious awards for excellence in clinical and laboratory research, and is the recipient of numerous awards from leading medical groups and patient advocacy associations.

The RMA Network

What's new?

Receive the latest updates from RMA!

RMANJ Research: Improving IVF

Original Research from RMANJ has Broad-Reaching Implications for Improving Success in IVF

Research Designated “Seminal Contribution” in April Issue of Fertility & Sterility

A new study conducted by Reproductive Medicine Associates of New Jersey has shown that an optimized method of Comprehensive Chromosome Screening (CCS) is the first technology capable of accurate aneuploidy screening (abnormal number of chromosomes) of all 24 chromosomes in four hours.

Learn more
Welcome to RMA of New York

This video introduces you to the world-renowned, full service fertility center, its Reproductive Endocrinologists, Urologist, Complementary Care team and highly qualified staff.

See Video